|
English
|
正體中文
|
简体中文
|
2832010
|
|
???header.visitor??? :
33593311
???header.onlineuser??? :
1141
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"narejos perez s"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2022-06-27T07:01:57Z |
Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: A phase III, randomized trial in adults aged ?18 years
|
Kieninger D.; Sheldon E.; Lin W.-Y.; CHONG-JEN YU; Bayas J.M.; Gabor J.J.; Esen M.; Fernandez Roure J.L.; Narejos Perez S.; Alvarez Sanchez C.; Feng Y.; Claeys C.; Peeters M.; Innis B.L.; Jain V. |
| 國立成功大學 |
2022 |
A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE)
|
Platt, H.L.;Cardona, J.F.;Haranaka, M.;Schwartz, H.I.;Narejos, Perez S.;Dowell, A.;Chang, Chang C.-J.;Dagan, R.;Tamms, G.M.;Sterling, T.;Morgan, L.;Shi, Y.;Pedley, A.;Musey, L.K.;Buchwald, U.K. |
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
